Related Experiment Video
Updated: Mar 11, 2026

Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
Gene Therapy for Post-infarction Ventricular Tachycardia
1Division of Cardiovascular Medicine, University of Massachusetts Medical School, 55 Lake Avenue, North, Worcester, MA, 01655, USA. donahuelab@gmail.com.
Researchers developed a new animal model and gene delivery method to study and treat ventricular tachyarrhythmias, a major cause of sudden cardiac death. This preclinical model holds promise for future gene therapies in clinical practice.
Area of Science:
- Cardiovascular Research
- Gene Therapy
- Animal Models
Background:
- Cardiac arrhythmias, particularly ventricular tachyarrhythmias, are a primary cause of sudden cardiac death.
- Myocardial infarction scars are frequently associated with fatal arrhythmias.
Purpose of the Study:
- To establish a reproducible animal model for inducible ventricular tachyarrhythmias post-myocardial infarction.
- To develop and validate a gene delivery method for targeting myocardial scar tissue.
Main Methods:
- Creation of a myocardial infarction scar in an animal model.
- Development of a gene delivery system for scar and surrounding myocardial tissues.
- Induction of ventricular tachyarrhythmias in the established model.
Main Results:
- The animal model reproducibly exhibits inducible ventricular tachyarrhythmias after myocardial infarction healing.
- The gene delivery method successfully targets scar and adjacent myocardial tissues.
Conclusions:
- This preclinical model and gene delivery system are valuable tools for investigating ventricular tachyarrhythmia mechanisms.
- The approach facilitates efficacy testing of novel gene therapies for arrhythmias.
- Potential for future translation to clinical applications in treating sudden cardiac death.
More Related Videos
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
05:15Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
Published on: July 27, 2022
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Myocarditis III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Dysrhythmias VI: Management of Dysrhythmias
Heart Failure Drugs: Inotropic Agents
Cardiomyopathy V: Interprofessional Care